Drugs / tanshinone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01452477 Comparator | Oct 2011 → Dec 2013 | polycystic ovary syndrome | Heilongjiang University of Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tanshinone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01452477 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “In Chinese medicine, this herb has been widely prescribed for several pathologies” NCT01452477 ↗ |
| Route | Oral | “tanshinone 1.0g / time, 3 times / day orally, continuous treatment for 12 weeks.” NCT01452477 ↗ |